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We recently reported3) a rule for resin selection routinely
used in tert-butyloxycarbonyl (Boc)-peptide synthesis chem-
istry.4,5) This study was based upon the quantitative determi-
nation of the lability of model peptidyl-resin linkages to-
wards both TFA amine group deprotection and HF final pep-
tide cleavage steps. These effects depend basically upon the
lability of the peptide-resin linkage which, in turn, is affected
by the resin itself, the C-terminal amino acid and how often
this chemical bond is submitted to TFA treatment (possibility
of premature chain loss) during peptide growth. A rule for
the choice of the best resin to be used depending on the pep-
tide sequence to be synthesized was proposed. However, due
to well-known practical and safety problems concerning use
of the HF method, other acidolytic strategies have been pro-
posed in the literature.6—8) The present work alternatively
evaluates the potentiality of the TFMSA/TFA/thioanisole
cleavage method9—11) for Boc-solid phase synthesis.
Thus, the present investigation reports data found in the
time-course study of TFMSA/TFA/thioanisole treatment of
peptidyl-resins using solid supports routinely applied for
Boc-peptide synthesis chemistry. Amongst these, the ben-
zhydrylamine-resin (BHAR)12) and methylbenzhydrylamine-
resin (MBHAR)13) are both used for the synthesis of peptide-
amides and 4-(oxymethyl)-phenylacetamidomethyl-resin
(PAMR)14) for peptide-acids. The vasoactive angiotensin II
(AII, DRVYIHPF)15) and its [Gly8]-AII analogue were se-
lected. Although this cleavage procedure is used routinely at
low temperature in solution synthesis,16,17) we decided to
compare the rate of peptide chain removal from a total of six
peptidyl-resins at both 0 °C and 25 °C. Therefore, the main
goal was to investigate the influence of different factors upon
the efficacy of the TFMSA/TFA method. These findings
would further facilitate the resin selection to be used and the
correct protocol for application of the acid cleavage method
which may depend on the type of peptide sequence to be as-
sembled.
Table 1 shows the TFMSA/TFA/thioanisole comparative
cleavage yields at 0 °C of Phe or Gly-bearing AII at its C-ter-
minal position and bound to BHAR, MBHAR and PAMR.
As expected [Gly8]-AII was much more easily removed from
the resin than the hydrophobic or larger Phe residue-contain-
ing AII sequence. If the lability dependence to the type of
resin was considered, the following decreasing order of 
peptidyl-resin stability was observed: BHAR.MBHAR.
PAMR. Intriguingly, the higher lability of peptide linkage to
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As an extension of our investigation of peptidyl-resin linkage stability towards different cleavage procedures
used in the solid-phase peptide synthesis (SPPS) technique, the present paper evaluated the trifluoromethanesul-
fonic acid (TFMSA)/trifluoroacetic acid (TFA)/thioanisole method, varying the type of resin (benzhydrylamine-
resin, BHAR; methylbenzhydrylamine-resin, MBHAR and 4-(oxymethyl)-phenylacetamidomethyl-resin, PAMR)
and peptide resin-bound residue (Gly and Phe). The vasoactive angiotensin II (AII, DRVYIHPF) and its [Gly8]-
AII analogue linked to those resins used routinely in tert-butyloxycarbonyl (Boc)-SPPS chemistry were submitted
comparatively to a time course study towards TFMSA/TFA cleavage. At 0 °C, [Gly8]-AII was completely removed
from all resins in less than 6 h, but the hydrophobic Phe8 moiety-containing AII sequence was only partially
cleaved (not more than 15%) from BHAR or MBHAR in this period. At 25 °C, [Gly8]-AII cleavage time de-
creased to less than 2 h irrespective of the solid support, and quantitative removal of AII from PAMR and
MBHAR occurred in less than 3 h. However, about 10—15 h seemed to be necessary for cleavage of AII from
BHAR, and in this extended cleavage reaction a significant increase in peptide degradation rate was observed.
Regardless of the cleavage temperature used, the decreasing order of acid stability measured for resins was
BHAR.MBHAR.PAMR. Collectively, these findings demonstrated the feasibility of applying TFMSA/TFA so-
lution as a substitute for anhydrous HF at the cleavage step in Boc-SPPS methodology. Care should be taken
however, as the cleavage efficacy depends on multiple factors including the resin, peptide sequence, the time and
temperature of reaction.
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0.5 1 2 4 6
[Gly8]AII-BHAR 15 39 62 83 100
[Gly8]AII-MBHAR 37 64 100 — —
[Gly8]AII-PAMR 78 91 100 — —
[Phe8]AII-BHAR 0 0 0 1 5
[Phe8]AII-MBHAR 0 1 6 12 13
[Phe8]AII-PAMR 38 82 100 — —
PAMR than to MBAR is not in agreement with previous re-
sults obtained during peptidyl-resin HCl/propionic acid hy-
drolysis18) or time course HF and TFA3) investigations.
The [Gly8]-AII sequence was completely removed in ap-
proximately 2 h from PAMR and MBHAR and in 6 h from
BHAR at 0 °C, while the more stable [Phe8]-AII-resin link-
age was cleaved quantitatively in 2 h from PAMR but only
partially from MBHAR or BHAR. At this low temperature,
the yield of [Phe8]-AII cleavage bound to these two amine-
resins reached values as low as 13 and 5%, respectively, after
extended 6 h reaction. By comparing results earlier reported
for these two peptidyl-resins at 0 °C in HF,3) the apparent rate
of cleavage seems to be higher in this than in the TFMSA/
TFA-containing mixed solution.
In an advantage over the HF method where use of a low
temperature is mandatory,19) the TFMSA/TFA strategy might
allow an increase in temperature during the cleavage process.
Table 2 displays the time course data obtained at 25 °C. As
expected, [Gly8]-AII removal from MBHAR and BHAR was
accelerated (around 2 and 3 h, respectively) but for the more
acid stable [Phe8]-AII-resin linkage, the peptide sequence
was only quantitatively cleaved after approximately 3 h and
10—20 h when bound to MBHAR and BHAR, respectively.
At this latter forceful cleavage condition, a decrease in the
peptide purity was monitored through analytical RP-HPLC.
Figure 1 shows the corresponding chromatogram profiles
of crude AII cleaved from BHAR in 1, 6 and 24 h with
TFMSA/TFA at 25 °C. After a cleavage time of nearly 6 h, it
is possible to see the appearance of a contaminant overlapped
with the AII main peak (at around 6 min) which increased
significantly in the 24 h-cleavage time HPLC profile. By
quantifying the main peak area in each displayed chro-
matogram, it is possible to conclude that peptide degradation
yield reached values around 20—25% in 24 h. Certainly this
degradation rate might be more related to AII-type sequence.
Further experimental investigations are needed with other se-
quences to better evaluate the validity in associating high
temperature with extended cleavage reaction time.
Lastly, to better evaluate the rule for TFMSA/TFA applica-
tion depending upon the resin, peptide length and the nature
of its C-terminal residue, Table 3 presents the theoretical
syntheses yield estimated when, for instance, cleavage of a
short and long (16 and 40-mer) peptide sequence is to be car-
ried out at 0 °C and 25 °C. For this estimation, the most com-
mon 2 h-cleavage time was employed for quantitative estima-
tion of the overall decrease in synthesis yield. These values
were obtained by considering simultaneously the already
quantified yield of chain loss of these peptides during 8 and
20 h-TFA deprotection3) (corresponding to 30 min treatment
of both 16 and 40 amino acid-long peptides) and the incom-
plete TFMSA/TFA cleavage values displayed in Tables 1 and
2. This was done simply by multiplying the yield of both acid
treatments, in percentage. It must be stressed that no other
source of side reactions or chemical problems during the
synthesis was considered, other than that derived from the
TFA and final cleavage steps.
The analysis of data displayed in Table 3, in association
with those of Tables 1 and 2 provided the following conclu-
sions/comments:
(i) Despite the resin or peptide sequence, PAMR is always
adequate for TFMSA/TFA cleavage regardless of tempera-
ture. The lowest yield when using this resin (88%, Table 3)
can be estimated, when a 40-mer long sequence is going to
be synthesized. The 12% decrease in the yield is essentially
due to the chain loss during the prolonged (20 h) TFA treat-
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Fig. 1. RP-HPLC Profiles of the [Phe8]-AII-BHAR after 1, 6 and 24 h TFMSA/TFA/Thioanisole Treatment at 25 °C
Table 2. Percentage of TFMSA/TFA/Thioanisole Cleavage of AA8-AII-
Resins at 25 °C
Cleavage time (h)
Peptidyl-resin
0.5 1 2 3 4 6 24
[Gly8]AII-BHAR 75 88 97 100 — — —
[Gly8]AII-MBHAR 87 96 100 — — — —
[Phe8]AII-BHAR — 20 70 73 84 87 100
[Phe8]AII-MBHAR — 49 89 100 — — —
ment. No decrease in the yield is due to the cleavage step as
it is complete in the 2 h-reaction.
(ii) Regarding MBHAR solid support, the feasibility of the
use of TFMSA/TFA cleavage procedure is highly dependent
on the nature of the C-terminal residue. For a hydrophilic and
small amino acid such as Gly, it is possible to obtain over
85% synthesis yield, regardless of the temperature used in
the reaction. However, its use is limited in the case of pep-
tides with hydrophobic C-terminal residues such as Phe.
Synthesis yield of about 80% (even at 25 °C) and not higher
than 6% (at 0 °C) are expected when cleaving Phe-MBHAR-
type compound for 2 h.
(iii) As expected, more severe restriction for use of the
TFMSA/TFA method is observed when BHAR is employed.
Acceptable yield is only obtained at higher temperature
(25 °C) and when the peptide contains Gly-type hydrophilic
residues at its carboxy-terminal portion. For sequences con-
taining hydrophobic moiety at this position, the synthesis
yield using BHAR does not reach 70% even at 25 °C, in the
standardized 2 h cleavage protocol. This finding is relevant as
we have already demonstrated that depending upon the pep-
tide length and the nature of its C-terminal residue, BHAR is
more appropriate than MBHAR for peptide synthesis.3) This
is basically due to higher acid stability of peptide-BHAR
linkage which avoids premature peptide chain detachment
from the resin during the prolonged TFA treatment.
(iv) To protect the peptide integrity when solution synthe-
sis is used, most chemists carry out TFMSA/TFA cleavage at
0 °C. Our results emphasized that neither MBHAR nor
BHAR can be employed at this low-temperature condition
when attaching peptides containing hydrophobic residue at
their C-terminal position. In this case, syntheses yields
around 6% and zero are estimated for these two resins, re-
spectively. In the more severe case (BHAR), even if a peptide
sequence containing hydrophilic moiety at its C-terminal
portion is synthesized, the final yield did not achieve values
higher than 60% (Table 3).
In conclusion, the feasibility of using the TFMSA/TFA/
thioanisole cleavage procedure for Boc-SPPS was demon-
strated but with some restrictions. Higher cleavage tempera-
ture combined with extended reaction time might be a valid
alternative to overcome some of these problems. Care should
be taken in this case, mainly concerning possible degradation
of the peptide sequence containing acid-labile residues. De-
spite this shortcoming the most relevant advantage of the
TFMSA/TFA method lies in its simplicity and safety com-
pared with the HF procedure which requires a special per-
flon-type apparatus and the handling of a very dangerous
vapor acid.
Since its inception, the SPPS methodology has been pro-
gressively improved through a great variety of experimental
investigations aiming for instance, to overcome incomplete
a-amine group deprotection,20) difficulties in coupling reac-
tions with the use of efficient acylating reagent,21,22) elevated
temperature23,24) or by enhancing the knowledge of the pep-
tidyl-resin solvation phenomenon.25,26) Spectroscopic tech-
niques of NMR,27,28) IR29,30) or EPR31,32) with the use of a
paramagnetic amino acid33) or associated with fluorescence34)
have been intensively applied to achieve the same objective.
In this context, the decrease in overall synthesis yield due to
premature chain detachment in the TFA step combined with
possible incomplete peptide cleavage from the resin has been
routinely neglected. The present work emphasized that de-
pending upon the chemical strategy to be used, this decrease
in synthesis yield as a consequence of these two acid steps of
the synthesis cycle can be comparatively relevant.
Experimental
Most of the solvents and reagents were purchased from Fluka or Aldrich
and all met ACS standards. Trifluoroacetic acid was acquired from Fluka
and the anhydrous hydrogen fluoride (5 l capacity cylinder) was from Merck
Co.
Peptide Synthesis Stepwise build-up of the peptides was done manually
by Boc-chemistry solid phase methodology. Benzhydrylamine resin
(BHAR), methylbenzhydrylamine resin (MBHAR) and 4-(oxymethyl)-
phenylacetamidomethyl-linker-containing resins (PAMR) with substitution
degree ranging from 0.2 to 0.6 mmol/g were used. These resins were ac-
quired from different companies (Advanced Chemtech, Novabiochem,
Peninsula and Bachem). The Na-tert-butyloxycarbonyl (Boc) protecting
group was removed with 30% trifluoroacetic acid (TFA) in dichloromethane
(DCM) in the presence of 2% anisole for 30 min. The following side chain
protecting groups were used: mesitylene-2-sulfonyl (Mts) for Arg and ben-
zyloxymethyl (Bom) for His, 2-bromobenzyloxycarbonyl (2-BrZ) for Tyr
and cyclohexyl group (cHex) for Asp. Amine group neutralization was per-
formed for 131 min and 1310 min with 10% triethylamine (TEA). Cou-
pling reactions were done using 2.5 excess of Boc-amino acid/2-(1H-benzo-
triazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU)/diiso-
propylethylamine (DIEA) (1 : 1 : 2) in DCM or in 1 : 1 (v/v) DCM/dimethyl-
formamide (DMF) mixture. All couplings were monitored by qualitative
ninhydrin test. Before TFMSA and TFA time-course investigations, a small
amount of each sample was cleaved by HF. The purity of the crude peptide
was assessed by analytical reverse-phase high performance liquid chro-
matography (RP-HPLC) and the structure was confirmed by the LC/MS and
amino acid analysis.
Amino Acid Analysis Prior to the TFMSA and TFA time-course stud-
ies, all peptidyl-resins were hydrolyzed with 12 N HCl/propionic acid mix-
ture for 100 h at 130 °C to guarantee quantitative removal of peptide chains
from the resin as recently proposed.18) Pyrex tubes with plastic Teflon-coated
screw caps (1331 cm) were used for the hydrolyses and the amino acid
analyses were performed in a Beckman System 6300 amino acid analyzer to
determine the amount of peptide attached to the resin.
TFMSA/TFA/Thioanisole Time Course Cleavage Study In several
small round-bottom flasks equipped with a micro stirring bar, 50 m l of m-
cresol and 124 m l of thioanisole were added to isolated portions of protected
peptide-resins (approximately 50 mg each). After stirring for approximately
2 min, 736 m l of TFA and 90 m l of TFMSA were added to each flask at 0 °C
or 25 °C. Each resin underwent for cleavage reaction for different periods of
time and was submitted to exhaustive washings with TFA/DCM, DCM, ethyl
acetate, DMF, water, 10% AcOH/water and MeOH to guarantee the removal
of all cleaved peptides and other side products of the reaction. After this
treatment, small aliquots of each dried resin were hydrolyzed according to
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Table 3. Theoretical Synthesis Yield of Model Peptidyl-Resins Consider-
ing the TFA and 2 h TFMSA/TFA/Thioanisole Treatments at 0 °C and
25 °Ca)
Theoretical yield (%)
Resins BHAR MBHAR PAMR
Number of residues 16 40 16 40 16 40
C-terminal residue 0 °C
Gly 60 57 96 86 96 88
Phe 0 0 6 5 96 91
25 °C
Gly 94 89 96 86 96 88
Phe 68 67 86 81 96 91
a) No other sources of error or side reactions were considered in this study other than
those derived from partial TFMSA/TFA/thioanisole or TFA peptide chain cleavages.
the previous report18) for further amino acid analysis. The calculated peptide
content of the cleaved resin was compared to the value of the initial pep-
tidyl-resin, taken as 100%. Otherwise when the purity of removed peptide
was to be evaluated, the cleaved peptide was isolated by precipitation with
cold ethyl ether in the resin, further extracted with 10% AcOH/water and
lyophilized.
Analytical RP-HPLC RP-HPLC analyses were achieved in TFA/ace-
tonitrile gradient using a Waters Associates HPLC system consisting of two
510 HPLC pumps, automated gradient controller, Rheodyne manual injec-
tor, 486 UV detector and 746 data module. Solvent A: 0.1% TFA/H2O and
Solvent B: 60% acetonitrile/0.1% TFA/H2O with a gradient of 5—95% of B
in 30 min, at a flow rate of 1.5 ml/min were used. The column employed was
a Vydac C18 column (0.46325 cm, 5 mm particle size, 300 Å pore size), and
detection at l5210 nm.
Liquid Chromatography/Mass Spectrometry The crude lyophilized
peptides were analyzed on a system composed of a Micromass Platform
LCZ Spectrometer, a Waters Alliance HPLC, a Waters 996 photodiode array
detector, and a Compaq Workstation. The peptides were loaded on a re-
versed-phase HPLC column Waters Nova-Pak C18 (2.13150 mm23.5 mm
particle size, and 60 Å pore size), Solvent A, 0.1% TFA/H2O, and B, 0.1%
TFA in CH3CN/H2O at a flow rate of 0.4 ml/min, detection at 210 nm in a
mass range of 500—3930 daltons.
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